Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases

Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases

US Patent 11084860 · Granted Aug 10, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2025
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2025
Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovari2024
Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovari2024
High-dose statins for age-related macular degeneration2023
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2022
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2022
High-dose statins for age-related macular degeneration2022